Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Expert Opinion on Investigational Drugs
|
February 2, 2022
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST)
Christopher Wynne, Christian Schwabe, Charlotte Lemech, et al.
Nutrients
|
March 10, 2022
The Effects of Commonly Consumed Dietary Fibres on the Gut Microbiome and Its Fibre Fermentative Capacity in Adults with Inflammatory Bowel Disease in Remission
Konstantinos Gerasimidis, Ben Nichols, Mhairi McGowan, et al.
Inflammatory Bowel Diseases
|
January 31, 2026
Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study
Esmée Helen Boute, Laura Gianolio, Shaden Mahmmod, et al.
Proteomics. Clinical Applications
|
December 8, 2010
A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans
Joshua Boateng, Richard Kay, Lee Lancashire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2009
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
Sanjiv S Agarwala, Ulrich Keilholz, Erard Gilles, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 17, 2025
Oxidised Apolipoprotein Peptidome Characterises Metabolic Dysfunction-Associated Steatotic Liver Disease
Gabriele Mocciaro, Amy L George, Michael Allison, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 17, 2021
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study
Steven R Feldman, Nataliya Reznichenko, Grazyna Pulka, et al.
Physics in Medicine and Biology
|
November 11, 2014
A method for quantitative analysis of regional lung ventilation using deformable image registration of CT and hybrid hyperpolarized gas/1H MRI
Bilal A Tahir, Andrew J Swift, Helen Marshall, et al.
Neurology
|
December 1, 2022
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses
Kyriakos Martakis, Jens Claassen, Jordi Gascon-Bayari, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
February 9, 2026
Glucagon may be extracted across the liver by glucagon-receptor dependent mechanism, and this is impaired in an animal model of fatty liver disease
Cecilie C N Huynh, Josephine Fisker-Andersen, Richard Kay, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Expert Opinion on Investigational Drugs
|
February 2, 2022
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST)
Christopher Wynne, Christian Schwabe, Charlotte Lemech, et al.
Nutrients
|
March 10, 2022
The Effects of Commonly Consumed Dietary Fibres on the Gut Microbiome and Its Fibre Fermentative Capacity in Adults with Inflammatory Bowel Disease in Remission
Konstantinos Gerasimidis, Ben Nichols, Mhairi McGowan, et al.
Inflammatory Bowel Diseases
|
January 31, 2026
Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study
Esmée Helen Boute, Laura Gianolio, Shaden Mahmmod, et al.
Proteomics. Clinical Applications
|
December 8, 2010
A proteomic approach combining MS and bioinformatic analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans
Joshua Boateng, Richard Kay, Lee Lancashire, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2009
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
Sanjiv S Agarwala, Ulrich Keilholz, Erard Gilles, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 17, 2025
Oxidised Apolipoprotein Peptidome Characterises Metabolic Dysfunction-Associated Steatotic Liver Disease
Gabriele Mocciaro, Amy L George, Michael Allison, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 17, 2021
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study
Steven R Feldman, Nataliya Reznichenko, Grazyna Pulka, et al.
Physics in Medicine and Biology
|
November 11, 2014
A method for quantitative analysis of regional lung ventilation using deformable image registration of CT and hybrid hyperpolarized gas/1H MRI
Bilal A Tahir, Andrew J Swift, Helen Marshall, et al.
Neurology
|
December 1, 2022
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses
Kyriakos Martakis, Jens Claassen, Jordi Gascon-Bayari, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
February 9, 2026
Glucagon may be extracted across the liver by glucagon-receptor dependent mechanism, and this is impaired in an animal model of fatty liver disease
Cecilie C N Huynh, Josephine Fisker-Andersen, Richard Kay, et al.
Page
of 6